Veeral Desai - 21 Jul 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
21 Jul 2022
Net transactions value
-$2,113,852
Form type
4
Filing time
25 Jul 2022, 16:16:40 UTC
Previous filing
11 Jul 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $79,768 +79,768 +29% $1.00* 357,979 21 Jul 2022 Direct F1
transaction AGL Common Stock Sale $2,193,620 -79,768 -22% $27.50 278,211 21 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -79,768 -58% $0.000000 57,441 21 Jul 2022 Common Stock 79,768 $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 These options were granted on April 27, 2017 and fully vested on April 27, 2021.